Global action plan for influenza vaccines

Dr Hongjie Yu

Director, Division for Infectious Diseases, Chinese Center for Disease Control and Prevention (China CDC)

Dr Hongjie Yu is charged with developing and supervising China’s national infectious disease surveillance systems, and supervises rapid response teams to provide technical support for the detection and response of emerging infections. He also leads the development of China’s national strategy for the control and prevention of infectious diseases. In addition, he acts as Principal Investigator for several research efforts in emerging infectious diseases in China, and is Conjunctive Director coordinating with WHO, US CDC, NIH, Oxford University, Wellcome Trust and other technical agencies.

Dr Yu graduated with his MD in 1994, after which he immediately joined the Expanded Program on Immunization Division of the China CDC, spending seven years in Liaoning province eradicating polio and elimination of measles. After being selected in 2001 to train in China CDC’s new field epidemiology training program, he was appointed after only two years in 2003 to Chief of the Respiratory Infectious Disease Branch of the Office for Disease Control and Emergency Response, China CDC, where he remained until accepting a new position as the Deputy director of the Office for Disease Control and Emergency Response in 2006. As of 2010, he is also guest researcher at the Centers for Disease Control and Prevention, Atlanta, GA, USA. In 2012, he was promoted to his present role as the Acting Director, Division for Infectious Diseases, China CDC.

His research interests include the epidemiology, transmission dynamics, and surveillance of infectious diseases such as SARS, avian and swine influenza, Hand Food Mouth Disease, Rabies, Brucellosis, and Streptococcus suis, as well as seasonal influenza, pneumococcal and Hib diseases. His research on vaccines for these diseases, including their efficacy, safety, and cost effectiveness, aims to help develop immunization services and evidence-based vaccination recommendations and policy.

Share